Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort.

MLA

Maggi, Paolo, et al. “Cardiovascular Risk in Advanced Naïve HIV-Infected Patients Starting Antiretroviral Therapy: Comparison of Three Different Regimens - PREVALEAT II Cohort.” Atherosclerosis, vol. 263, Aug. 2017, pp. 398–404. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2017.05.004.

APA

Maggi, P., Bellacosa, C., Leone, A., Volpe, A., Ricci, E. D., Ladisa, N., Cicalini, S., Grilli, E., Viglietti, R., Chirianni, A., Bellazzi, L. I., Maserati, R., Martinelli, C., Corsi, P., Celesia, B. M., Sozio, F., & Angarano, G. (2017). Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort. Atherosclerosis, 263, 398–404. https://doi.org/10.1016/j.atherosclerosis.2017.05.004

Chicago

Maggi, Paolo, Chiara Bellacosa, Armando Leone, Anna Volpe, Elena Delfina Ricci, Nicoletta Ladisa, Stefania Cicalini, et al. 2017. “Cardiovascular Risk in Advanced Naïve HIV-Infected Patients Starting Antiretroviral Therapy: Comparison of Three Different Regimens - PREVALEAT II Cohort.” Atherosclerosis 263 (August): 398–404. doi:10.1016/j.atherosclerosis.2017.05.004.